{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:21:59Z","timestamp":1787559719903,"version":"build-2736575974"},"reference-count":130,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Empire Innovation Professorship at SUNY, Buffalo and NIH","award":["R01EB027078"],"award-info":[{"award-number":["R01EB027078"]}]},{"name":"Empire Innovation Professorship at SUNY, Buffalo and NIH","award":["R01HL185536"],"award-info":[{"award-number":["R01HL185536"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Acute and chronic inflammation underlies the pathogenesis of numerous diseases, including autoimmune disorders, atherosclerosis, infections, and cancer. Although non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids are widely used to control inflammation, their clinical utility is limited by adverse effects such as gastrointestinal toxicity and immunosuppression. Specialized pro-resolving mediators (SPMs), a family of endogenous lipid mediators derived from omega-3 fatty acids, have emerged as promising therapeutics because they actively promote the resolution of inflammation without suppressing host immunity. However, their clinical translation is hindered by poor chemical stability, rapid metabolic degradation, and short circulation half-lives. To overcome these limitations, a variety of delivery platforms\u2014including liposomes, extracellular vesicles, PLGA nanoparticles, and hydrogels\u2014have been developed to improve SPM stability, pharmacokinetics, and therapeutic efficacy. This review summarizes the cellular targets of SPMs, current delivery challenges, and emerging strategies for cell- and tissue-specific SPM delivery. We also discuss future opportunities for targeted SPM therapies in the treatment of inflammatory diseases and cancer.<\/jats:p>","DOI":"10.3390\/pharmaceutics18091048","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:03:41Z","timestamp":1787558621000},"page":"1048","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted Delivery of Specialized Pro-Resolving Mediators (SPMs) for Improved Treatments of Inflammatory Diseases and Cancer"],"prefix":"10.3390","volume":"18","author":[{"given":"Adeola","family":"Aminu","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Division of Drug Delivery and Pharmaceutical Bioengineering, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, SUNY, Buffalo, NY 14215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1155-1935","authenticated-orcid":false,"given":"Zhenjia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Division of Drug Delivery and Pharmaceutical Bioengineering, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, SUNY, Buffalo, NY 14215, USA"},{"name":"Department of Biomedical Engineering, School of Engineering and Applied Sciences, and Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, Buffalo, NY 14260, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2010.03.006","article-title":"Inflammation 2010: New adventures of an old flame","volume":"140","author":"Medzhitov","year":"2010","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.20170681","article-title":"Resolvins suppress tumor growth and enhance cancer therapy","volume":"215","author":"Sulciner","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.pathmechdis.3.121806.151409","article-title":"Anti-inflammatory and proresolving lipid mediators","volume":"3","author":"Serhan","year":"2008","journal-title":"Annu. Rev. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and protectins in inflammation resolution","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1054\/jpai.2000.16611","article-title":"Limitations of NSAIDs for pain management: Toxicity or lack of efficacy?","volume":"1","author":"Payne","year":"2000","journal-title":"J. Pain"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"oyaf045","DOI":"10.1093\/oncolo\/oyaf045","article-title":"Balancing immunotherapy and corticosteroids in cancer treatment: Dilemma or paradox?","volume":"30","author":"Ottaiano","year":"2025","journal-title":"Oncologist"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2017.03.001","article-title":"Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology","volume":"58","author":"Serhan","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: Signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: Endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jasms.2006.09.002","article-title":"Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray\/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms","volume":"18","author":"Hong","year":"2007","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.0907342107","article-title":"Resolvin D1 binds human phagocytes with evidence for proresolving receptors","volume":"107","author":"Krishnamoorthy","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation","volume":"282","author":"Sun","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20150225","article-title":"Identification of resolvin D2 receptor mediating resolution of infections and organ protection","volume":"212","author":"Chiang","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/BJ20110327","article-title":"Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution","volume":"437","author":"Fredman","year":"2011","journal-title":"Biochem. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2353\/ajpath.2010.100322","article-title":"Novel lipid mediators and resolution mechanisms in acute inflammation: To resolve or not?","volume":"177","author":"Serhan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: Emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbalip.2010.08.002","article-title":"Specialized pro-resolving lipid mediators in the inflammatory response: An update","volume":"1801","author":"Bannenberg","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mam.2017.02.003","article-title":"Specialized pro-resolving mediators in cardiovascular diseases","volume":"58","author":"Fredman","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.116.307308","article-title":"Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology","volume":"119","author":"Sansbury","year":"2016","journal-title":"Circ. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"353ra111","DOI":"10.1126\/scitranslmed.aaf7483","article-title":"Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses","volume":"8","author":"Chiurchiu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coi.2017.10.007","article-title":"Immunoresolvents signaling molecules at intersection between the brain and immune system","volume":"50","author":"Dalli","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/CCM.0000000000002014","article-title":"Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations with Survival and Clinical Outcomes","volume":"45","author":"Dalli","year":"2017","journal-title":"Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/CIRCRESAHA.119.315506","article-title":"Enriched Marine Oil Supplements Increase Peripheral Blood Specialized Pro-Resolving Mediators Concentrations and Reprogram Host Immune Responses: A Randomized Double-Blind Placebo-Controlled Study","volume":"126","author":"Souza","year":"2020","journal-title":"Circ. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: A new therapeutic frontier","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.tips.2015.07.007","article-title":"Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation","volume":"36","author":"Perretti","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","article-title":"Specific lipid mediator signatures of human phagocytes: Microparticles stimulate macrophage efferocytosis and pro-resolving mediators","volume":"120","author":"Dalli","year":"2012","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood.2021013422","article-title":"Resolvin T-series reduce neutrophil extracellular traps","volume":"139","author":"Chiang","year":"2022","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized Pro-Resolving Mediator Network: An Update on Production and Actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"112740","DOI":"10.1016\/j.intimp.2024.112740","article-title":"The chemically stable analogue of resolvin D1 ameliorates experimental autoimmune encephalomyelitis by mediating the resolution of inflammation","volume":"140","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/cts.12930","article-title":"Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically-Based Pharmacokinetic Modeling","volume":"14","author":"Yellepeddi","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Dalli, J., and Serhan, C.N. (2017). Pro-Resolving Mediators in Regulating and Conferring Macrophage Function. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01400"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Thornton, J.M., and Yin, K. (2021). Role of Specialized Pro-Resolving Mediators in Modifying Host Defense and Decreasing Bacterial Virulence. Molecules, 26.","DOI":"10.3390\/molecules26226970"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1208\/s12248-018-0200-2","article-title":"Targeting Inflammatory Vasculature by Extracellular Vesicles","volume":"20","author":"Wang","year":"2018","journal-title":"AAPS J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e1706245","DOI":"10.1002\/adma.201706245","article-title":"Neutrophil-Based Drug Delivery Systems","volume":"30","author":"Chu","year":"2018","journal-title":"Adv. Mater."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11800","DOI":"10.1021\/acsnano.5b05583","article-title":"Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection","volume":"9","author":"Chu","year":"2015","journal-title":"ACS Nano"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1701021","DOI":"10.1002\/adma.201701021","article-title":"Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration","volume":"29","author":"Chu","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/adhm.201500998","article-title":"Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy","volume":"5","author":"Chu","year":"2016","journal-title":"Adv. Healthc. Mater."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e70063","DOI":"10.1002\/mco2.70063","article-title":"Neutrophil heterogeneity and plasticity: Unveiling the multifaceted roles in health and disease","volume":"6","author":"He","year":"2025","journal-title":"MedComm"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1111\/bph.15919","article-title":"Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35","volume":"179","author":"Qin","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"18232","DOI":"10.1073\/pnas.1308253110","article-title":"Ligand-specific conformational change of the G-protein-coupled receptor ALX\/FPR2 determines proresolving functional responses","volume":"110","author":"Cooray","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1021\/jm501051x","article-title":"FPR2\/ALXR Agonists and the Resolution of Inflammation","volume":"58","author":"Corminboeuf","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Filep, J.G. (2022). Targeting Neutrophils for Promoting the Resolution of Inflammation. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.866747"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.smim.2016.03.007","article-title":"The role of neutrophils in inflammation resolution","volume":"28","author":"Jones","year":"2016","journal-title":"Semin. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"14983","DOI":"10.1073\/pnas.1206641109","article-title":"Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation","volume":"109","author":"Gjorstrup","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e2302938120","DOI":"10.1073\/pnas.2302938120","article-title":"Resolvin D1 prevents injurious neutrophil swarming in transplanted lungs","volume":"120","author":"Li","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e22173","DOI":"10.1096\/fj.202101219RR","article-title":"Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis","volume":"36","author":"Kraft","year":"2022","journal-title":"FASEB J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e2308511120","DOI":"10.1073\/pnas.2308511120","article-title":"The total mass, number, and distribution of immune cells in the human body","volume":"120","author":"Sender","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zhang, J., Wang, M., Ye, J., Liu, J., Xu, Y., Wang, Z., Ye, D., Zhao, M., and Wan, J. (2020). The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00203"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1111\/jcmm.15436","article-title":"Resolvin D1 and D2 inhibit tumour growth and inflammation via modulating macrophage polarization","volume":"24","author":"Shan","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"L888","DOI":"10.1152\/ajplung.00125.2015","article-title":"Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages","volume":"309","author":"Croasdell","year":"2015","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41565-024-01687-1","article-title":"Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment","volume":"19","author":"He","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"ref_57","first-page":"60","article-title":"Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: Inhibition of inflammation by resolvin D1","volume":"1","author":"Liu","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Liotti, F., Marotta, M., Melillo, R.M., and Prevete, N. (2022). The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression. Cancers, 14.","DOI":"10.3390\/cancers14143333"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1096\/fj.201600375R","article-title":"Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes","volume":"30","author":"Croasdell","year":"2016","journal-title":"FASEB J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1753425916628618","article-title":"Resolvin D1, resolvin D2 and maresin 1 activate the GSK3beta anti-inflammatory axis in TLR4-engaged human monocytes","volume":"22","author":"Gu","year":"2016","journal-title":"Innate Immun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.3324\/haematol.2019.219519","article-title":"Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction","volume":"105","author":"Kooij","year":"2020","journal-title":"Haematologica"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Torres, W., P\u00e9rez, J.L., D\u00edaz, M.P., D\u2019Marco, L., Checa-Ros, A., Carrasquero, R., Angarita, L., G\u00f3mez, Y., Chac\u00edn, M., and Ram\u00edrez, P. (2023). The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612623"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Oner, F., Alvarez, C., Yaghmoor, W., Stephens, D., Hasturk, H., Firatli, E., and Kantarci, A. (2021). Resolvin E1 Regulates Th17 Function and T Cell Activation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.637983"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4049\/jimmunol.1103483","article-title":"Specialized Proresolving Mediators Enhance Human B Cell Differentiation to Antibody-Secreting Cells","volume":"189","author":"Ramon","year":"2012","journal-title":"J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/eji.201545673","article-title":"Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production","volume":"46","author":"Kim","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e70026","DOI":"10.1111\/bcpt.70026","article-title":"Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction","volume":"136","author":"Briones","year":"2025","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7150\/thno.18069","article-title":"Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites","volume":"7","author":"Dong","year":"2017","journal-title":"Theranostics"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4155\/tde-2017-0081","article-title":"Neutrophil-mediated delivery of nanotherapeutics across blood vessel barrier","volume":"9","author":"Dong","year":"2018","journal-title":"Ther. Deliv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nnano.2014.17","article-title":"Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils","volume":"9","author":"Wang","year":"2014","journal-title":"Nat. Nanotechnol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1021\/nn9012274","article-title":"Size and dynamics of caveolae studied using nanoparticles in living endothelial cells","volume":"3","author":"Wang","year":"2009","journal-title":"ACS Nano"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI131609","article-title":"GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections","volume":"130","author":"Flak","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Qiu, D., Xu, K., Chung, N., Robbins, J., Luo, R., Lawrence, M., He, A., Yu, F., Alt, A., and Miller, M.M. (2023). Identification and validation of G protein-coupled receptors modulating flow-dependent signaling pathways in vascular endothelial cells. Front. Mol. Biosci., 10.","DOI":"10.3389\/fmolb.2023.1198079"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2016.01.024","article-title":"Cell membrane-formed nanovesicles for disease-targeted delivery","volume":"224","author":"Gao","year":"2016","journal-title":"J. Control Release"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biomaterials.2017.05.003","article-title":"High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy","volume":"135","author":"Gao","year":"2017","journal-title":"Biomaterials"},{"key":"ref_75","first-page":"1272","article-title":"Neutrophil Membrane-Derived Nanovesicles Alleviate Inflammation To Protect Mouse Brain Injury from Ischemic Stroke","volume":"13","author":"Dong","year":"2019","journal-title":"ACS Nano"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.actbio.2021.01.020","article-title":"Human neutrophil membrane-derived nanovesicles as a drug delivery platform for improved therapy of infectious diseases","volume":"123","author":"Gao","year":"2021","journal-title":"Acta Biomater."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s42003-020-01410-5","article-title":"Co-delivery of resolvin D1 and antibiotics with nanovesicles to lungs resolves inflammation and clears bacteria in mice","volume":"3","author":"Gao","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/gutjnl-2013-306445","article-title":"Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid","volume":"63","author":"Cockbain","year":"2014","journal-title":"Gut"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1804000116","article-title":"Aspirin-triggered proresolving mediators stimulate resolution in cancer","volume":"116","author":"Gilligan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13046-021-01937-3","article-title":"Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes","volume":"40","author":"Mattoscio","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_81","first-page":"598","article-title":"Neutrophils in cancer: From immune defense to tumor promotion","volume":"22","author":"Wang","year":"2025","journal-title":"Cancer Biol. Med."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Lavy, M., Gauttier, V., Poirier, N., Barille-Nion, S., and Blanquart, C. (2021). Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.702785"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41418-019-0370-1","article-title":"Resolvin D1 promotes the targeting and clearance of necroptotic cells","volume":"27","author":"Gerlach","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"D\u2019Eliseo, D., and Velotti, F. (2016). Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy. J. Clin. Med., 5.","DOI":"10.3390\/jcm5020015"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1021\/ar200044b","article-title":"Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy","volume":"44","author":"Xie","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1476-511X-10-159","article-title":"Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro","volume":"10","author":"Das","year":"2011","journal-title":"Lipids Health Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1158\/1940-6207.CAPR-11-0298","article-title":"Phase II Prospective Randomized Trial of a Low-Fat Diet with Fish Oil Supplementation in Men Undergoing Radical Prostatectomy","volume":"4","author":"Aronson","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1158\/1940-6207.CAPR-13-0261","article-title":"Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomy","volume":"7","author":"Galet","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12937-017-0295-9","article-title":"The effects of EPA and DHA enriched fish oil on nutritional and immunological markers of treatment naive breast cancer patients: A randomized double-blind controlled trial","volume":"16","author":"Paixao","year":"2017","journal-title":"Nutr. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biocel.2013.09.018","article-title":"Resolvin D1 inhibits TGF-beta1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor\/formyl peptide receptor 2 and GPR32","volume":"45","author":"Lee","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3892\/or.2015.4095","article-title":"Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review)","volume":"34","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.nbt.2009.03.016","article-title":"Natural antibodies and cancer","volume":"25","author":"Vollmers","year":"2009","journal-title":"New Biotechnol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/biof.1668","article-title":"Resolvin D1 protects against sepsis-induced cardiac injury in mice","volume":"46","author":"Wang","year":"2020","journal-title":"Biofactors"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1021\/acs.molpharmaceut.0c00299","article-title":"Molecular Dynamics Simulations Provide Insight into the Loading Efficiency of Proresolving Lipid Mediators Resolvin D1 and D2 in Cell Membrane-Derived Nanovesicles","volume":"17","author":"Gc","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/jbm.a.37512","article-title":"Sustained release resolvin D1 liposomes are effective in the treatment of osteoarthritis in obese mice","volume":"111","author":"Dravid","year":"2023","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e10281","DOI":"10.1002\/btm2.10281","article-title":"Resolvin D1-loaded nanoliposomes promote M2 macrophage polarization and are effective in the treatment of osteoarthritis","volume":"7","author":"Dravid","year":"2022","journal-title":"Bioeng. Transl. Med."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Kaur, P., Gao, J., and Wang, Z. (2022). Liposomal Formulations Enhance the Anti-Inflammatory Effect of Eicosapentaenoic Acid in HL60 Cells. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14030520"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s12951-022-01652-x","article-title":"Targeted delivery and ROS-responsive release of Resolvin D1 by platelet chimeric liposome ameliorates myocardial ischemia\u2013reperfusion injury","volume":"20","author":"Weng","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acsnano.3c09848","article-title":"Engineered Biomimetic Nanovesicles Based on Neutrophils for Hierarchical Targeting Therapy of Acute Respiratory Distress Syndrome","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biochi.2020.07.013","article-title":"Extracellular vesicles of MSCs and cardiomyoblasts are vehicles for lipid mediators","volume":"178","author":"Pizzinat","year":"2020","journal-title":"Biochimie"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Sanchez-Rodriguez, M.B., Tellez, E., Casulleras, M., Borras, F.E., Arroyo, V., Claria, J., and Sarrias, M.R. (2022). Reduced Plasma Extracellular Vesicle CD5L Content in Patients with Acute-On-Chronic Liver Failure: Interplay with Specialized Pro-Resolving Lipid Mediators. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.842996"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2204822","DOI":"10.1002\/adfm.202204822","article-title":"Biomimetic Macrophage Membrane and Lipidated Peptide Hybrid Nanovesicles for Atherosclerosis Therapy","volume":"32","author":"Guo","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.actbio.2017.02.020","article-title":"Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling","volume":"53","author":"Sok","year":"2017","journal-title":"Acta Biomater."},{"key":"ref_106","first-page":"100126","article-title":"Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries","volume":"4","author":"Levy","year":"2023","journal-title":"JVS-Vasc. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/acsabm.5c01880","article-title":"Intelligent Responsive PLGA-ES100 Composite Nanoparticles Loaded with Resolvin E1 for Inflammation Regulation Behavior","volume":"9","author":"Sun","year":"2026","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Xing, Z., Liu, J., Cai, J., Jiang, X., Liang, J., Fujio, M., Hadler-Olsen, E., Wang, J., Kantarci, A., and Xue, Y. (2024). The Application of Resolvin D1-Loaded Gelatin Methacrylate in a Rat Periodontitis Model. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17010016"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13346-024-01588-9","article-title":"Influence of physico-chemical properties of two lipoxin emulsion-loaded hydrogels on pre-polarized macrophages: A comparative analysis","volume":"15","author":"Guyon","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/s43018-025-01029-7","article-title":"A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer","volume":"6","author":"Wang","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/17425247.2013.751370","article-title":"Targeted drug delivery to macrophages","volume":"10","author":"Jain","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1016\/j.biomaterials.2012.06.025","article-title":"In vivo targeting of alveolar macrophages via RAFT-based glycopolymers","volume":"33","author":"Song","year":"2012","journal-title":"Biomaterials"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1211\/jpp.59.1.0010","article-title":"Uptake characteristics of liposomes by rat alveolar macrophages: Influence of particle size and surface mannose modification","volume":"59","author":"Chono","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.7150\/thno.29146","article-title":"Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases","volume":"9","author":"Yap","year":"2019","journal-title":"Theranostics"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1208\/s12248-015-9766-0","article-title":"Antibody Drug Conjugates: Application of Quantitative Pharmacology in Modality Design and Target Selection","volume":"17","author":"Sadekar","year":"2015","journal-title":"AAPS J."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Su, D., and Zhang, D. (2021). Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.687926"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13238-016-0323-0","article-title":"Antibody-drug conjugates: Recent advances in conjugation and linker chemistries","volume":"9","author":"Tsuchikama","year":"2018","journal-title":"Protein Cell"},{"key":"ref_118","first-page":"694","article-title":"Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma","volume":"5","author":"Ye","year":"2020","journal-title":"Bioact. Mater."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"14655","DOI":"10.1038\/s41598-017-14709-x","article-title":"Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide","volume":"7","author":"Scodeller","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e2201443119","DOI":"10.1073\/pnas.2201443119","article-title":"Scavenger receptor-targeted plaque delivery of microRNA-coated nanoparticles for alleviating atherosclerosis","volume":"119","author":"Bai","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1142\/S1793984410000183","article-title":"TARGETING OF MACROPHAGE FOAM CELLS IN ATHEROSCLEROTIC PLAQUE USING OLIGONUCLEOTIDE-FUNCTIONALIZED NANOPARTICLES","volume":"1","author":"Sharma","year":"2010","journal-title":"Nano Life"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"13121","DOI":"10.1021\/acsnano.2c08275","article-title":"Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain","volume":"17","author":"Nong","year":"2023","journal-title":"ACS Nano"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/1535370217693116","article-title":"Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis","volume":"242","author":"Khodabandehlou","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12951-018-0431-5","article-title":"Anti-ICAM-1 antibody-modified nanostructured lipid carriers: A pulmonary vascular endothelium-targeted device for acute lung injury therapy","volume":"16","author":"Li","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1625149","DOI":"10.1155\/2016\/1625149","article-title":"P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation","volume":"2016","author":"Simion","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"11243","DOI":"10.1021\/nn503732m","article-title":"Platelet-like Nanoparticles: Mimicking Shape, Flexibility, and Surface Biology of Platelets To Target Vascular Injuries","volume":"8","author":"Anselmo","year":"2014","journal-title":"ACS Nano"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Kim, D., Wu, Y., Shim, G., and Oh, Y.-K. (2021). Lipid Nanoparticle-Mediated Lymphatic Delivery of Immunostimulatory Nucleic Acids. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040490"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"L904","DOI":"10.1152\/ajplung.00370.2014","article-title":"Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent","volume":"308","author":"Orr","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1039\/C8OB01232F","article-title":"Synthesis of protectin D1 analogs: Novel pro-resolution and radiotracer agents","volume":"16","author":"Tungen","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e70746","DOI":"10.1002\/ctm2.70746","article-title":"Engineered probiotics platform for resolvin E1 biosynthesis confers protection against inflammatory disease","volume":"16","author":"Li","year":"2026","journal-title":"Clin. Transl. Med."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1048\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:04:57Z","timestamp":1787558697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,23]]},"references-count":130,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["pharmaceutics18091048"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18091048","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,23]]}}}